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Background: Impaired lung function is associated with mortality rate from cardiovascular and all other death causes. 
There were previous studies on the relationship between lung function impairment and metabolic syndrome, but they 
are insufﬁ  cient. This study was conducted on Koreans to analyze each component of metabolic syndrome as well as its 
variability between sexes.
Methods: 1,370 subjects underwent a health examination at the Eulji General Hospital Health Center. We examined the 
association between lung function measurement (forced expiratory volume for 1 second [FEV1], forced vital capacity 
[FVC], FEV1/FVC) and metabolic syndrome using Student t-test, Pearson partial correlation coefﬁ  cient, and analysis of 
covariance for statistical analysis, and we adopted metabolic syndrome deﬁ  ned by American Heart Association/National 
Heart, Lung, and Blood Institute in Asia.
Results: Men with metabolic syndrome tended to experience lung function impairment. In terms of association to 
each metabolic syndrome component, metabolic syndrome components in men were associated with pulmonary 
function impairment and the more metabolic syndrome diagnostic criteria factors the patients had, the more severe 
their pulmonary function tended to decline. In women, waist circumference, triglyceride and high-density lipoprotein 
cholesterol were associated with pulmonary function change.
Conclusion: In men, all metabolic syndrome components were associated with pulmonary function impairment, and 
the more metabolic syndrome components men had, the more severe their pulmonary functions decline. In women, 
components of metabolic syndrome were not associated with pulmonary function impairment.
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INTRODUCTION
As the obese population increases, the incidence of 
metabolic syndrome is also increasing. There has been a recent 
report
1-4) on the relationship between the diagnostic criteria of 
metabolic syndrome or changes in the pulmonary function and 
cardiovascular mortality and total mortality. As such, there is 
increasing interest in changes in metabolic syndrome associated 
with changes in pulmonary function.
In a number of recent studies, it was reported that among  Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
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the changes in pulmonary function, pulmonary function, 
deterioration is related to hypertension, type 2 diabetes, low-
density lipoprotein cholesterol, overall obesity, abdominal 
obesity and insulin resistance.
5-9) Among the above listed factors, 
hypertension, diabetes, and abdominal obesity are included 
as diagnostic criteria for metabolic syndrome, hence it can be 
inferred that identifying the relationship between metabolic 
syndrome and pulmonary function deterioration is meaningful.
In a study on the relationship between pulmonary function 
deterioration and metabolic syndrome, pulmonary function 
deterioration was detected where there is metabolic syndrome. 
Even when gender, age, smoking status, alcohol drinking and 
physical activity factors were reflected, limited pulmonary 
function deterioration showed independent relevance to 
increased risk of metabolic syndrome.
8)
Obese people have shown signs of pulmonary function 
deterioration,
8-9) hence, a simple pulmonary function test 
during health examination can be used as a predictive factor for 
metabolic syndrome in obese people.
As such, this study will look into the relationship based 
on the changes in metabolic syndrome diagnostic criteria and 
pulmonary function indices, like forced expiratory volume for 
1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC 
ratio.
METHODS
1. Subjects
Th   is study targeted those who underwent a health examina-
tion at the Eulji General Hospital Health Center between January 
2, 2008 and August 13, 2008. Th   e age of the subjects ranged from 
over 20 to under 70 years old, and included 1,370 people out 
of the total 1,566 patients. The subjects who reported a clinical 
history on cardiovascular disease (myocardial infarct, angina 
pectoris) and pulmonary disease (asthma, chronic obstructive 
pulmonary disease) or cancer, were excluded based on their 
survey answers. Those with no pulmonary function test results 
or body measurements (waist circumference, height) were also 
excluded.
2. Measurements
1) Survey
Prior to conducting the general health examination, patients’ 
consent was att  ained to conduct a survey. Th   e patients were asked 
to record specifi  cally their past clinical history, the types of drugs 
they are taking, their alcohol and smoking history, and physical 
activity level, etc. Th   ose who found it diffi   cult to fi  ll out the survey 
were assisted by nurses.
As for physical activity level, subjects were classifi  ed into 1) 
light activity: walking for less than 2 hours a day, working in an 
office, or working as a housewife with little household chores, 
2) medium level activity: walking for 2-4 hours a day, working 
in manufacturing or service industry, or working as a housewife 
with a lot of household chores, 3) hard activity: working in 
agriculture, fi  shery, civil engineering or construction industry, 4) 
severe activity: athletes, or those who transport wood or engage 
in farming work during farming season.
2) Physical measurement
Waist circumference was measured from the center point 
of the last rib and iliac spine. Height and weight were measured 
while wearing light clothing (health examination gown). For 
obesity level, body mass index (BMI) was used, which is the value 
att  ained by dividing the body weight (kg) against the height (m
2), 
to classify the subjects into obese (BMI ≥ 25 kg/m
2), overweight 
(23 kg/m
2 ≤ BMI < 25 kg/m
2) and normal weight (BMI < 23 
kg/m
2) groups. With the blood test, triglyceride, high-density 
lipoprotein cholesterol (HDL-C), and fasting blood sugar were 
measured. Blood pressure was measured using an automatic 
sphygmomanometer aft  er taking over 5 minutes of rest.
3) Pulmonary function test
Pulmonary function was measured between 8 AM and 12 
PM using a spirometer (model 2130; SensorMedics Co., Yorba 
Linda, CA, USA). Subject was in a seated position, and the 
measurement was taken by an experienced nurse. To reduce any 
variance in measurement by the person taking the measurement 
the same nurse measured everyone. The values measured were 
FEV1, FVC, FEV1/FVC.Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
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3. Definition of Metabolic Syndrome
Metabolic syndrome, based on the Asia criteria of the 
American Heart Association/National Heart, Lung, and Blood 
Institute,
10) is diagnosed when 3 out of the following 5 categories 
are satisfi  ed: 1) blood pressure of systolic blood pressure ≥ 130 
mm Hg or diastolic blood pressure ≥ 85 mm Hg, or is taking a 
hypertension drug, 2) fasting blood sugar ≥ 100 mg/dL, or is 
taking a diabetes drug, 3) triglyceride ≥ 150 mg/dL, or is taking 
a dyslipidemia drug, 4) low HDL-C (male < 40 mg/dL, female 
< 50 mg/dL), or is taking a dyslipidemia drug, or 5) the waist 
circumference applied is male ≥ 90 cm, female ≥ 80 cm. Also, 
female waist circumference of over 85 cm was also applied based 
on the Korean Society for the Study of Obesity.
11)
4. Statistical Analysis
The data was shown as mean ± standard deviation. For 
the difference in variables among the groups, Student t-test 
and χ2-test were used. For the relationship between each of the 
metabolic syndrome factors and pulmonary function, Pierson 
partial correlation coeffi   cient was used, having modifi  ed the age 
and height factors. For the existence of metabolic syndrome and 
the relationship with pulmonary function, analysis of covariance 
was used by controlling the physical activity level and smoking 
level. Th   is data was analyzed by using SPSS ver. 12.0 (SPSS Inc., 
Chicago, IL, USA).
RESULTS
1. General Characteristics
Average age of men and women was 44.07 ± 10.12 years 
old (male) and 43.11 ± 11.50 years old (female), respectively. 
Pulmonary function fi  gures were higher in women than men. As 
for BMI, men’s average was 24.51 ± 2.97 kg/m
2 and women’s 
average was 22.77 ± 3.28 kg/m
2. Th   e ratio of obese people (BMI 
≥ 25 kg/m
2) was 42.9% and 23.7%, respectively, for men and 
women. Th   e distribution of metabolic syndrome was statistically 
higher for men than women at 25.5% versus 17.3%. Women had 
lower triglyceride and fasting blood sugar levels than men, but 
HDL-C was statistically higher. In men, systolic blood pressure 
was 122.09 ± 13.05 mm Hg and diastolic blood pressure was 
72.87 ± 9.94 mm Hg, which is statistically higher than women’
s systolic blood pressure of 116.33 ± 14.68 mm Hg and diastolic 
blood pressure of 69.14 ± 9.80 mm Hg.
As for the smoking ratio, current smoker ratio stands at 47.8% 
for men and 6.3% for women, showing a higher smoking rate in 
men with higher total smoking volume (Table 1).
2. Relationship between Diagnostic Criteria 
for Metabolic Syndrome and Pulmonary 
Function
Among males, there were big diff  erences in FVC according 
to whether or not he had metabolic syndrome. In fact, the 
FVC difference was 83.42 ± 10.08%, 87.47 ± 10.19% (P < 
0.001). In addition, people with waist circumference of 90 cm 
or above had FVC of 84.05 ± 9.99%, while for those with waist 
circumference below 90 cm it was 87.72 ± 10.26% (P < 0.001). 
Moreover, FVC of people with above 150 mg/dL of triglyceride 
was 84.66 ± 9.78% while it was 87.46 ± 10.58% (P < 0.001) for 
those with triglyceride of below 150 mg/dL. In particular, waist 
circumference and triglyceride showed the most significant 
difference of P < 0.001. On the other hand, FEV1 was 97.43 ± 
12.21% for triglyceride levels above 150 mg/dL, while below 150 
mg/dL, FEV1 recorded was 99.87 ± 12.85% (P < 0.01). As such, 
the difference was only evident between metabolic syndrome 
and triglyceride level. Th  e  FEV1/FVC ratio diff  erence was found 
to be correlated only to waist circumference. Among females, 
FVC didn’t show any signifi  cant diff  erence in any of these items. 
FEV1 showed a difference according to whether or not she had 
metabolic syndrome and waist circumference of 85 cm and 80 
cm, respectively, and whether the HDL-C level was high or low. 
However, there was no correlation found between FEV1 and 
pulmonary function. Th  e  FEV1/FVC ratio diff  erence was found 
among those females with waist circumference of 85 cm or above 
and whether or not she had triglyceride and metabolic syndrome 
(Table 2).
In order to identify correlation between metabolic syndrome 
and pulmonary function, we have controlled the level of smoking 
and degree of physical activity, which all have influence on 
pulmonary function. When smoking and degree of physical 
activity were controlled, males showed significant correlation 
between metabolic syndrome and FVC, while females showed 
signifi  cant correlation between metabolic syndrome and FEV1/
FVC (No table was provided). Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
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3. Correlation between Diagnostic Criteria 
for Metabolic Syndrome and Pulmonary 
Function
When age, height as well as total smoking amount were 
factored in, FVC showed significant negative correlation with 
waist circumference & triglyceride levels among males, while it 
showed positive correlation with HDL-C. In particular, waist 
circumference with a value of P < 0.001 showed a high level of 
negative correlation. FEV1 showed negative correlation with 
triglyceride levels, while FEV1/FVC ratio showed positive 
correlation with waist circumference. Meanwhile, females showed 
no correlation with pulmonary function measurement value as 
well as metabolic syndrome component (Table 3).
Table 1. Characteristics of participants.
Variables Men (n = 715) Women (n = 655)
Age (y)  44.07 ± 10.12  43.11 ± 11.50
FEV1*  98.93 ± 12.65 101.10 ± 14.91
FVC  86.38 ± 10.37  87.31 ± 11.25
FEV1/FVC (%)* 87.20 ± 6.34 89.15 ± 6.50
Body mass index (kg/m
2)* 24.51 ± 2.97 22.77 ± 3.28
WC (cm)* 87.02 ± 7.75 77.97 ± 8.86
TG (mg/dL)*  152.64 ± 102.04  96.66 ± 63.86
HDL-C (mg/dL)*  50.88 ± 11.40  59.30 ± 12.67
FBG (mg/dL)* 101.75 ± 26.00  93.86 ± 19.36
BP , systolic (mm Hg)*  122.09 ± 13.05 116.33 ± 14.68
BP , diastolic (mm Hg)* 72.87 ± 9.94 69.14 ± 9.80
Smoking status*
None 229 (32.00) 574 (87.60)
Past 107 (15.00)  7 (1.10)
Current 342 (47.80) 41 (6.30)
Lifetime smoking (pack/y)* 17.07 ± 13.39 8.75 ± 9.92
Alcohol drinking*
None 100 (14.00) 341 (52.10)
Past  8 (1.10)  6 (1.00)
Current 573 (80.10) 273 (41.70)
Physical activities*
Stage 1 459 (79.10) 416 (78.30)
Stage 2  82 (14.10) 110 (20.50)
Stage 3 33 (5.70) 10 (1.90)
Stage 4  6 (1.00)  1 (0.20)
Values are presented as mean ± SD or number (%). P-values are for Student’s t-test and χ
2-test.
FEV1: forced expiratory volume for 1 second, FVC: forced vital capacity, WC: waist circumference, TG: triglyceride, HDL-C: high-density 
lipoprotein cholesterol, FBG: fasting blood sugar, BP: blood pressure.
*Gender comparison (P < 0.001).Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
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Table 2. Relationship of metabolic syndrome components and pulmonary functions.
Variables FEV1 (%) FVC (%) FEV1/FVC (%)
Men (n = 715)
MS* Yes  97.21 ± 12.60
†  83.42 ± 10.08
‡ 87.82 ± 5.90
No  99.60 ± 12.54
†  87.47 ± 10.19
‡ 86.99 ± 6.48
WC (cm) ≥90
§ 98.00 ± 12.47 84.05 ± 9.99
‡ 88.00 ± 5.35
†
<90  99.52 ± 12.63  87.72 ± 10.26
‡ 86.77 ± 6.79
†
TG (cm) ≥150
∥   97.43 ± 12.21
¶ 84.66 ± 9.78
‡ 87.51 ± 6.64
<150   99.87 ± 12.85
¶  87.46 ± 10.58
‡ 87.00 ± 6.14
HDL-C (mg/dL) <40**  97.35 ± 12.00  84.06 ± 10.02
† 87.66 ± 5.52
≥40  99.20 ± 12.75  86.78 ± 10.38
† 87.12 ± 6.47
FBS (mg/dL) ≥100
††  98.75 ± 12.26 85.18 ± 10.43
† 87.38 ± 6.04
<100  99.03 ± 12.87 87.03 ± 10.28
† 87.10 ± 6.50
BP (mm Hg) ≥130/85
‡‡  98.29 ± 13.53 85.06 ± 11.01
† 86.89 ± 6.72
<130/85  99.23 ± 12.22 87.00 ± 10.00
† 87.34 ± 6.16
Women (n = 655)
MS* Yes 104.09 ± 14.40
† 86.40 ± 11.25 90.59 ± 5.23
¶
No 100.50 ± 14.96
† 87.53 ± 11.25 88.85 ± 6.71
¶
WC (cm) ≥85
§ 105.61 ± 14.27
‡ 87.98 ± 11.69 90.55 ± 4.98
¶
<85  99.96 ± 14.87
‡ 87.13 ± 11.16 88.80 ± 6.79
¶
WC (cm) ≥80 103.36 ± 14.80
¶ 87.63 ± 11.56 89.50 ± 6.02
<80  99.66 ± 14.82
¶ 87.09 ± 11.08 88.93 ± 6.79
TG (mg/dL)  ≥150
∥ 104.24 ± 15.02
† 86.70 ± 11.44 90.33 ± 5.51
†
<150 100.56 ± 14.83
† 87.42 ± 11.23 88.95 ± 6.64
†
HDL-C (mg/dL) ≤50** 103.87 ± 13.95
† 87.93 ± 11.35 90.00 ± 5.59
>50 100.31 ± 15.09
† 87.13 ± 11.23 88.91 ± 6.73
FBG (mg/dL) ≥100
†† 102.12 ± 13.62 86.17 ± 10.60 89.86 ± 5.39
<100 100.85 ± 15.21 87.59 ± 11.40 88.98 ± 6.74
BP (mm Hg) ≥130/85
‡‡ 103.17 ± 15.06 86.12 ± 11.57 89.93 ± 6.36
<130/85 100.60 ± 14.84 87.68 ± 11.15 88.95 ± 6.54
Values are presented as mean ± SD. P-values are for Student’s t-test.
FEV1: forced expiratory volume for 1 second, FVC: forced vital capacity, MS: metabolic syndrome, WC: waist circumference, TG: 
triglyceride, HDL-C: high-density lipoprotein cholesterol, FBS: fasting blood sugar, BP: blood pressure, AHA/NHLBI: American Heart 
Association/National Heart, Lung, and Blood Institute.
*Diagnostic criteria of AHA/NHLBI (Asian). 
†P < 0.05. 
‡P < 0.001. 
§Diagnostic criteria of AHA/NHLBI & waist circumference (Korean 
women). 
∥TG ≥ 150 or dyslipidemia drug intake. 
¶P < 0.01. **HDL-C < 40 (men), 50 (women) or dyslipidemia drug intake. 
††FBS ≥ 100 or 
diabetes drug intake. 
‡‡BP ≥ 130/85 or hypertension drug intake. Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
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Table 3. Partial correlation coefﬁ  cients adjusted for age, height, smoking.
Men (n = 715) Women (n = 655)
FEV1 FVC FEV1/FVC FEV1 FVC FEV1/FVC
WC -0.072 -0.189* 0.173
† -0.010  0.001 -0.023
TG -0.115
‡ -0.164
‡ 0.078 -0.007 -0.121  0.183
HDL-C 0.093 0.125
‡ -0.040 -0.058 -0.048 -0.066
BP , systolic -0.035 -0.065 0.046 -0.210 -0.292 0.081
BP , diastolic -0.057 -0.089 0.055 -0.173 -0.256 0.075
FBG -0.036 -0.027 0.008 -0.013 -0.208 0.274
P-values are for Pearson partial correlation coefﬁ  cients.
FEV1: forced expiratory volume for 1 second, FVC: forced vital capacity, WC: waist circumference, TG: triglyceride, HDL-C: high density 
lipoprotein cholesterol, BP: blood pressure, FBG: fasting blood sugar.
*P < 0.001. 
†P < 0.01. 
‡P < 0.05.
Figure 1. P-values are for analysis of covariance. The relationship between forced vital capacity (FVC) (A), forced expiratory volume for 1 
second (FEV1) (B) and number of American Heart Association/National Heart, Lung, and Blood Institute-number of adult treatment panel 
III metabolic syndrome components (NAMC). For men FVC and FEV1 were associated with NAMC. For women, there was no association 
between FVC, FEV1 and NAMC.Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
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4. The Relationship between Number of 
Components That Serve as the Criteria 
for Diagnosing Metabolic Syndrome and 
Pulmonary Function
Pulmonary function changed according to the degree of 
severity of metabolic syndrome. In the case of males, FVC 
declined as severity of metabolic syndrome increased, while there 
was no correlative relationship found among females (Figure 1).
DISCUSSION
Th   is study aimed to fi  nd relevance between components that 
serve as the criteria for diagnosing metabolic syndrome and poor 
performing pulmonary function. Among males, every diagnostic 
component of metabolic syndrome had significant correlation 
with poor pulmonary function. On the other hand, among 
females, FVC had a tendency of poor pulmonary function but 
with no signifi  cant relevance.
Many studies conclude that pulmonary function drops 
among obese people.
12,13) Previously, studies have used BMI, 
waist circumference, waist/hip circumference ratio, abdominal 
thickness (height) and skin thickness test as the markers that 
show obesity.
14-16) However, as of recent, studies focus on 
abdominal obesity as indicative of overall level of obesity. As 
such, this study tried to examine the waist circumference that 
demonstrates abdominal obesity as well as the relationship 
between metabolic syndrome components that are easily found 
among obese people and eff  ects these factors have on pulmonary 
function.
According to the study, reverse-correlation was found 
between diagnostic components of metabolic syndrome and 
pulmonary function. Among males, while there were signifi  cant 
diff  erences in FVC according to whether or not there were any 
diagnostics components for metabolic syndrome, there were no 
FVC diff  erences found among females. However, for both males 
and females, pulmonary function diff  ered signifi  cantly according 
to waist circumference. For males, there was a signifi  cant statistical 
difference in FVC and FEV1/FVC. In the case of females, for 
waist circumference of 85 cm, both FEV1 and FEV1/FVC had 
a significant statistical difference, while waist circumference of 
80 cm only showed a signifi  cant statistical diff  erence in FEV1. In 
particular, among males, the partial correlation coeffi   cient of waist 
circumference was FVC -0.189, FEV1/FVC 0.173.
According to a study conducted by Leone et al.,
17) both males 
and females showed reverse-correlation between all diagnostic 
components of metabolic syndrome and pulmonary function. 
As in this study, abdominal obesity was reported as the most 
powerful predictor of poor pulmonary function.
17) In addition, 
Chen et al.
18) found out that both males and females showed 
negative correlation between FEV1/FVC and waist circumference 
even after age, height, weight, workload, energy consumption, 
and smoking were factored in. Thus, the bigger the waist 
circumference becomes, the greater its impact on pulmonary 
function, eventually having partial impact on the movements 
of diaphragm and chest.
18) Canoy et al.
16) took the waist/hip 
circumference ratio as the indicator of abdominal obesity to verify 
that both FEV1 and FVC show reverse correlation both among 
males and females.
In Australia, Lazarus et al.
14) showed that FVC has negative 
correlation with males’ waist circumference and that no 
relationship was found among females.
14) Moreover, according 
to a study conducted by Ochs-Balcom et al.,
19) males’ FEV1 
and FVC showed negative correlation in all obesity markers 
(weight and level of obesity) as well as markers for abdominal 
obesity (waist circumference, ratio of waist/hip circumference, 
abdominal height). However, among females, only the abdominal 
height and waist circumference showed negative correlation with 
FEV1, while all markers of obesity showed negative correlation 
with FVC. In particular, the reverse relationship between FEV1 
and abdominal height was evident only among those obese 
people with BMI of over 25 kg/m
2.
19)
According to this study, in men, correlation between waist 
circumference and FVC, FEV1/FVC ratio was statistically 
significant in terms of partial correlation coefficient where age, 
height and total smoking amount was refl  ected. For women, the 
correlation was not statistically significant across all respiratory 
indexes. The results were similar to the research conducted by 
Harik-Khan et al.,
20) which showed that FVC and FEV1 and waist 
circumference and hip circumference had negative correlation for 
men, whereas for women, only FVC had correlation and FEV1 
showed no correlation. To explain such differences by gender, 
it could be assumed that fat distribution could aff  ect diaphragm 
and thoracic movements of women more than men and that  Myoung-Sook Bae, et al: The Relationship between Metabolic Syndrome and Pulmonary Function
Vol. 33, No. 2 Mar 2012  |  77 Korean J Fam Med
waist circumference and hip circumference ratio does not aff  ect 
pulmonary function.
20)
Carey et al.
21) said that changes in weight and obesity are 
related to FEV1 and in particular, weight increase of the group 
with the highest obesity level showed greater FEV1 reduction. 
Such results demonstrated a wider gap in men because male 
abdominal fat accumulated relatively more during the 7-year 
research period and in women, hip circumference tended to 
increase more. Thus, their increase in waist/hip circumference 
ratio was lower than men. Results of this study were also diff  erent 
by sex since males showed a higher level of obesity than women, 
with a higher ratio of men having abdominal fat.
Nakajima et al.
22) showed correlation between FVC and 
metabolic syndrome level, such as an increase in the sum 
of metabolic syndrome diagnostics factors. The research 
demonstrated that an increase in the severity of metabolic 
syndrome impairs lung function in men but not in women. 
Th   e results indicate that in addition to the relationship between 
each metabolic syndrome factor and weaker pulmonary 
function, people with more metabolic syndrome factors are 
more vulnerable to pulmonary function impairment. Th  erefore, 
additional studies on how to control these metabolic factors to 
infl  uence pulmonary function in metabolic patients is necessary.
Not much research has been conducted on the association 
between metabolic syndrome components and lung function 
impairment. Since such studies were almost non-existent in 
Korea, this research regarding pulmonary function impairment 
in Asians is very signifi  cant. It is also meaningful in showing the 
relationship between pulmonary function, metabolic syndrome, 
and sex, as such studies had never previously been performed.
However, given that the analysis was conducted on Koreans 
coming from a certain region and health examinees, it is hard 
to generalize the outcome of the research to all ethnic groups. 
Also, since women were not classified into groups before and 
after menopause, the results may not be statistically significant 
and should be validated further through additional research. Th  e 
research had some constraints as a cross-sectional study with not 
many morbidly obese patients included in the analysis. Further 
research should be conducted, and in particular, studies on 
morbidly obese patients are also necessary.
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